Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 0 | 0 | 4,252,000 |
| Depreciation Amortization | 0 | 0 | 0 | 0 | 708,000 |
| Other Working Capital | 0 | 0 | 0 | 0 | -513,000 |
| Other Operating Activity | 0 | 0 | 0 | 0 | -225,000 |
| Operating Cash Flow | $0 | $0 | $0 | $0 | $4,222,000 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | 0 | -4,779,000 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $-4,779,000 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 0 | 499,000 |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $499,000 |
| Net Cash Flow | $0 | $0 | $0 | $0 | $-58,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 0 | 0 | 0 | 0 | 4,222,000 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 4,222,000 |